The National Healthcare Security Administration said at its 1H 2026 briefing that drugs added to the 2025 national medical insurance drug list are stocked at about 310,000 designated medical institutions and have been used in more than 12.0 million patient visits. From Jan–May, the national medical insurance fund spent 2.636 bln yuan on these new drugs, supporting 3.946 bln yuan in drug sales. Uptake is pronounced for some high‑profile products: the hyperlipidemia treatment Yingkesilan is now av

Mainland A-shares popped and eased in the morning; by midday the Shanghai Composite was down 0.46%, the Shenzhen Composite down 0.35%, ChiNext up 0.13% and the Sci‑Tech 50 Index up 3.19%. Morning turnover across Shanghai and Shenzhen was CNY 1.7 trillion, down more than CNY 5 billion from the prior session. Over 4,600 stocks declined. Semiconductors led gains, led by memory-chip names — one stock jumped about 20% to above CNY 1,000 and several peers hit daily limit-up; multiple chip suppliers rose over 10%. Oil and gas names spiked then pulled back; Shandong Molong hit limit-up while several oil producers advanced. The lithium, battery and broader new-energy supply chain continued to fall, with a string of lithium and battery-related stocks hitting intraday limit-downs. Small metals and rare-earth-related names underperformed, and sectors including power-grid equipment, humanoid robots and lab-grown diamonds weakened.

Turkey's President Erdogan said US President Trump’s firm stance on efforts to achieve peace with Iran is admirable.